Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

NCT04004871 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma
Nasopharyngeal Cancer
Nasopharynx Cancer

Interventions

DRUG: Nab-paclitaxel, Cisplatin and Fluorouracil
RADIATION: concurrent chemoradiotherapy

Sponsor

Guangxi Medical University

Collaborators

[object Object]
[object Object]